Coalition of Inclusive Medicine

Coalition of Inclusive Medicine (CIM) is a clinical research organization and medical center based in Los Angeles, California, specializing in hepatology and infectious diseases. The organization operates the Asian Pacific Liver Center (APLC) and is dedicated to providing specialized care, screening, and clinical trial opportunities for conditions that disproportionately affect Asian American communities, such as chronic Hepatitis B and Hepatitis D. CIM serves as a prominent clinical trial site, collaborating with pharmaceutical sponsors and academic partners like Thomas Jefferson University to conduct Phase 1 through Phase 4 studies. Its mission focuses on improving health equity through community-based research, patient education, and the evaluation of advanced antiviral and oncological therapies.